Fosfomycin

Revision as of 19:02, 27 September 2011 by WikiBot (talk | contribs) (Protected "Fosfomycin": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Fosfomycin
File:Fosfomycin skeletal.svg
Clinical data
Pregnancy
category
  • US: B (No risk in non-human studies)
Routes of
administration
Oral
ATC code
Legal status
Legal status
Pharmacokinetic data
Bioavailability30–37% (oral, fosfomycin tromethamine); varies with food intake
Protein bindingNil
MetabolismNil
Elimination half-life5.7 hours (mean)
ExcretionRenal and fecal, unchanged
Identifiers
CAS Number
PubChem CID
DrugBank
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC3H7O4P
Molar mass138.059 g/mol

WikiDoc Resources for Fosfomycin

Articles

Most recent articles on Fosfomycin

Most cited articles on Fosfomycin

Review articles on Fosfomycin

Articles on Fosfomycin in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Fosfomycin

Images of Fosfomycin

Photos of Fosfomycin

Podcasts & MP3s on Fosfomycin

Videos on Fosfomycin

Evidence Based Medicine

Cochrane Collaboration on Fosfomycin

Bandolier on Fosfomycin

TRIP on Fosfomycin

Clinical Trials

Ongoing Trials on Fosfomycin at Clinical Trials.gov

Trial results on Fosfomycin

Clinical Trials on Fosfomycin at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Fosfomycin

NICE Guidance on Fosfomycin

NHS PRODIGY Guidance

FDA on Fosfomycin

CDC on Fosfomycin

Books

Books on Fosfomycin

News

Fosfomycin in the news

Be alerted to news on Fosfomycin

News trends on Fosfomycin

Commentary

Blogs on Fosfomycin

Definitions

Definitions of Fosfomycin

Patient Resources / Community

Patient resources on Fosfomycin

Discussion groups on Fosfomycin

Patient Handouts on Fosfomycin

Directions to Hospitals Treating Fosfomycin

Risk calculators and risk factors for Fosfomycin

Healthcare Provider Resources

Symptoms of Fosfomycin

Causes & Risk Factors for Fosfomycin

Diagnostic studies for Fosfomycin

Treatment of Fosfomycin

Continuing Medical Education (CME)

CME Programs on Fosfomycin

International

Fosfomycin en Espanol

Fosfomycin en Francais

Business

Fosfomycin in the Marketplace

Patents on Fosfomycin

Experimental / Informatics

List of terms related to Fosfomycin

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Fosfomycin (also known as phosphomycin and phosphonomycin) is a broad-spectrum antibiotic produced by certain Streptomyces species. It is indicated in the treatment of urinary tract infections. It is usually administered as fosfomycin tromethamine, trade name Monurol.

Fosfomycin is usually administered as a single dose.

See also

External links


Template:Other antibacterials

Template:SIB

Template:WH Template:WS